Skip to main content
Agilent Technologies, Inc. (A)
NYSE: A · Real-Time Price · USD
134.58
-0.96 (-0.71%)
Dec 30, 2024, 12:27 PM EST - Market open

Agilent Technologies Revenue by Segment
Period Ending Jul 31, 2024Apr 30, 2024Jan 31, 2024Oct 31, 2023Jul 31, 2023Apr 30, 2023Jan 31, 2023Oct 31, 2022Jul 31, 2022Apr 30, 2022Jan 31, 2022Oct 31, 2021Jul 31, 2021Apr 30, 2021Jan 31, 2021Oct 31, 2020Jul 31, 2020Apr 30, 2020Jan 31, 2020Oct 31, 2019
Life Sciences and Applied Markets Group
3.31B 3.46B 3.67B 3.86B 4.04B 4.14B 4.06B 4.01B
Life Sciences and Applied Markets Group Growth
-18.15% -16.47% -9.72% -3.77% 11.16% 25.37% 32.08% 41.94%
Agilent Crosslab Group
1.62B 1.61B 1.59B 1.57B 1.55B 1.51B 1.47B 1.45B
Agilent Crosslab Group Growth
4.98% 6.56% 8.01% 7.99% -5.96% -18.22% -27.28% -34.00%
Diagnostics and Genomics Group
1.57B 1.53B 1.47B 1.41B 1.41B 1.40B 1.39B 1.39B
Diagnostics and Genomics Group Growth
11.39% 9.53% 5.89% 1.44% 1.96% 0.87% 3.80% 7.18%

Revenue by End Market
Period Ending Jul 31, 2024Apr 30, 2024Jan 31, 2024Oct 31, 2023Jul 31, 2023Apr 30, 2023Jan 31, 2023Oct 31, 2022Jul 31, 2022Apr 30, 2022Jan 31, 2022Oct 31, 2021Jul 31, 2021Apr 30, 2021Jan 31, 2021Oct 31, 2020Jul 31, 2020Apr 30, 2020Jan 31, 2020Oct 31, 2019
Pharmaceutical and Biopharmaceutical
2.24B 2.29B 2.36B 2.43B 2.52B 2.58B 2.55B 2.52B
Pharmaceutical and Biopharmaceutical Growth
-11.37% -11.11% -7.56% -3.26% 3.83% 8.93% 10.67% 13.03%
Chemicals and Advanced Materials
1.49B 1.51B 1.53B 1.54B 1.59B 1.60B 1.55B 1.52B
Chemicals and Advanced Materials Growth
-5.99% -5.26% -1.61% 1.45% 9.38% 14.48% 13.10% 14.45%
Diagnostics and Clinical
945.00M 944.00M 955.00M 966.00M 975.00M 968.00M 959.00M 963.00M
Diagnostics and Clinical Growth
-3.08% -2.48% -0.42% 0.31% 1.14% -0.41% -0.52% 2.77%
Food
596.00M 603.00M 625.00M 628.00M 643.00M 643.00M 619.00M 617.00M
Food Growth
-7.31% -6.22% 0.97% 1.78% 7.71% 9.17% 3.86% 2.83%
Academia and Government
567.00M 585.00M 605.00M 601.00M 601.00M 594.00M 581.00M 576.00M
Academia and Government Growth
-5.66% -1.52% 4.13% 4.34% 3.80% 2.77% 1.04% -

Revenue by Instrumentation
Period Ending Jul 31, 2024Apr 30, 2024Jan 31, 2024Oct 31, 2023Jul 31, 2023Apr 30, 2023Jan 31, 2023Oct 31, 2022Jul 31, 2022Apr 30, 2022Jan 31, 2022Oct 31, 2021Jul 31, 2021Apr 30, 2021Jan 31, 2021Oct 31, 2020Jul 31, 2020Apr 30, 2020Jan 31, 2020Oct 31, 2019
Non Instrumentation and Other
4.11B 4.12B 4.12B 4.09B 4.07B 4.02B 3.96B 3.94B
Non Instrumentation and Other Growth
1.03% 2.41% 4.22% 3.81% 4.87% 4.58% 4.69% 7.62%
Instrumentation
2.39B 2.47B 2.61B 2.74B 2.92B 3.02B 2.98B 2.91B
Instrumentation Growth
-18.43% -18.09% -12.17% -5.68% 5.26% 12.57% 11.55% 9.41%

Revenue by Type
Period Ending Jul 31, 2024Apr 30, 2024Jan 31, 2024Oct 31, 2023Jul 31, 2023Apr 30, 2023Jan 31, 2023Oct 31, 2022Jul 31, 2022Apr 30, 2022Jan 31, 2022Oct 31, 2021Jul 31, 2021Apr 30, 2021Jan 31, 2021Oct 31, 2020Jul 31, 2020Apr 30, 2020Jan 31, 2020Oct 31, 2019
Products
4.69B 4.79B 4.94B 5.05B 5.23B 5.32B 5.25B 5.19B
Products Growth
-10.43% -9.95% -5.91% -2.62% 4.26% 8.49% 8.25% 9.06%
Services and Other
1.81B 1.80B 1.80B 1.78B 1.76B 1.72B 1.68B 1.66B
Services and Other Growth
2.78% 4.64% 6.83% 7.28% 7.38% 5.97% 5.32% 6.27%

Revenue by Geography
Period Ending Jul 31, 2024Apr 30, 2024Jan 31, 2024Oct 31, 2023Jul 31, 2023Apr 30, 2023Jan 31, 2023Oct 31, 2022Jul 31, 2022Apr 30, 2022Jan 31, 2022Oct 31, 2021Jul 31, 2021Apr 30, 2021Jan 31, 2021Oct 31, 2020Jul 31, 2020Apr 30, 2020Jan 31, 2020Oct 31, 2019
Americas
2.60B 2.64B 2.68B 2.73B 2.75B 2.75B 2.73B 2.68B
Americas Growth
-5.46% -4.11% -2.09% 1.86% 4.41% 7.22% 9.90% 11.56%
APAC
2.15B 2.21B 2.30B 2.35B 2.51B 2.58B 2.49B 2.47B
APAC Growth
-14.22% -14.40% -7.62% -4.86% 7.45% 14.38% 10.50% 10.78%
Europe
1.75B 1.75B 1.76B 1.75B 1.74B 1.71B 1.70B 1.70B
Europe Growth
0.58% 2.04% 3.05% 3.24% 2.66% 0.23% 0.12% 0.65%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.